Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati.
NEJM Evid. 2023 Oct;2(10):EVIDoa2300026. doi: 10.1056/EVIDoa2300026. Epub 2023 Aug 4.
Methods to determine whether a toddler is likely to develop asthma are of value to parents and clinical trialists testing primary prevention strategies. The Pediatric Asthma Risk Score (PARS) is a 14-point score of six factors designed to predict asthma in early life. PARS was developed and validated in relatively homogenous populations, so its generalizability is unknown. METHODS: We computed PARS using the six factors of self-declared race (parent-reported as “Black” or “not Black”), parental asthma, eczema, any wheezing, wheezing without a cold, and polysensitization in 5634 children from birth to 3 years of age. The primary outcome of our analysis was the ability of PARS to predict asthma development at 5 to 10 years of age using the area under the receiver operating curve in each cohort and across all cohorts with varying ethnicity, sex, cohort type, birth decades, missing PARS factors, and polysensitization definition. We also performed a meta-analysis across all the cohorts. Finally, we compared PARS predictive ability with the binary Asthma Predictive Index (API). RESULTS: Across 10 cohorts, the area under the receiver operating curve for PARS was 0.76. PARS performance did not differ by ethnicity, sex, cohort type, enrollment decade, missing PARS factors, or polysensitization definition (all P>0.05). The weights of each factor in the meta-analysis were similar to the original PARS weights. PARS and API equally identified children at high risk for developing asthma or not; API missed 31% of children at moderate asthma risk. CONCLUSIONS: PARS provided robust estimates of asthma risk in children from a wide range of ethnicities, backgrounds, and susceptibility. (Funded by the National Institute of Allergy and Infectious Diseases and others.)
确定幼儿是否可能患哮喘的方法对父母和临床试验者测试初级预防策略都具有重要价值。儿科哮喘风险评分(PARS)是一种 14 分的 6 因素评分,旨在预测早期生命中的哮喘。PARS 是在相对同质的人群中开发和验证的,因此其普遍性尚不清楚。方法:我们使用 6 个因素(父母报告为“黑人”或“非黑人”的自我报告种族、父母哮喘、湿疹、任何喘息、无感冒喘息和多敏化)计算了 5634 名儿童从出生到 3 岁的 PARS。我们分析的主要结果是使用每个队列和所有队列的接收者操作曲线下面积来预测 PARS 在 5 至 10 岁时发展为哮喘的能力,所有队列的种族、性别、队列类型、出生年代、缺失 PARS 因素和多敏化定义均有所不同。我们还对所有队列进行了荟萃分析。最后,我们比较了 PARS 预测能力与二元哮喘预测指数(API)。结果:在 10 个队列中,PARS 的接收者操作曲线下面积为 0.76。PARS 的表现不因种族、性别、队列类型、入组年代、缺失 PARS 因素或多敏化定义而有所不同(所有 P>0.05)。荟萃分析中每个因素的权重与原始 PARS 权重相似。PARS 和 API 同样能够识别出患有哮喘或不患有哮喘的高风险儿童;API 漏诊了 31%处于中度哮喘风险的儿童。结论:PARS 为来自不同种族、背景和易感性的儿童提供了可靠的哮喘风险估计。(由美国国立过敏和传染病研究所及其他机构资助)。